Literature DB >> 1888697

Positive and negative factors regulate the transcription of the ETS2 gene via an oncogene-responsive-like unit within the ETS2 promoter region.

G J Mavrothalassitis1, T S Papas.   

Abstract

The DNA-protein interactions in the ETS2 promoter have been studied. Three distinct sequence motifs have been identified, each of which interacts with at least two distinctive protein complexes. The GC motif, possessing mirror symmetry, interacts with two ubiquitously identifiable complexes (S and S2); the PEA3 motif interacts with a ubiquitous (H1) and a tissue-specific (H3) complex; the H2 (an AP1-like) motif interacts also with a ubiquitous (H2a) and a tissue-specific (H2b) complex. Mutational analysis and correlation of the presence of defined complexes with the ETS2 mRNA levels indicate that the S, S2, H1, and H2b complexes have positive effects on ETS2 transcription, whereas the H3 and H2a have negative effects. The organization of the PEA3 with the AP1-like motif in the ETS2 promoter resembles the oncogene-responsive unit previously identified in the polyoma virus enhancer region. Our data suggest that cooperation between these two motifs is vital for ETS2 promoter function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888697

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  7 in total

1.  Identification of a second promoter in the human c-ets-2 proto-oncogene.

Authors:  A Bègue; P Crepieux; N Vu-Dac; A Hautefeuille; N Spruyt; V Laudet; D Stehelin
Journal:  Gene Expr       Date:  1997

2.  Identification of a killer cell-specific regulatory element of the mouse perforin gene: an Ets-binding site-homologous motif that interacts with Ets-related proteins.

Authors:  H Koizumi; M F Horta; B S Youn; K C Fu; B S Kwon; J D Young; C C Liu
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

3.  GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes.

Authors:  N Bannert; A Avots; M Baier; E Serfling; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

4.  Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor.

Authors:  K J Stacey; L F Fowles; M S Colman; M C Ostrowski; D A Hume
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

5.  Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.

Authors:  Giuseppina M Carbone; Eileen M McGuffie; Angela Collier; Carlo V Catapano
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

6.  Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis.

Authors:  Stephen R F Twigg; Elena Vorgia; Simon J McGowan; Ioanna Peraki; Aimée L Fenwick; Vikram P Sharma; Maryline Allegra; Andreas Zaragkoulias; Elham Sadighi Akha; Samantha J L Knight; Helen Lord; Tracy Lester; Louise Izatt; Anne K Lampe; Shehla N Mohammed; Fiona J Stewart; Alain Verloes; Louise C Wilson; Chris Healy; Paul T Sharpe; Peter Hammond; Jim Hughes; Stephen Taylor; David Johnson; Steven A Wall; George Mavrothalassitis; Andrew O M Wilkie
Journal:  Nat Genet       Date:  2013-01-27       Impact factor: 38.330

7.  ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.

Authors:  D N Sgouras; M A Athanasiou; G J Beal; R J Fisher; D G Blair; G J Mavrothalassitis
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.